Overview
Injective (INJ) and CHEEMS (CHEEMS) sit at different layers of the crypto stack. At current prices ($5.15 vs $1,880.52), market leadership still favors Injective on capitalization, while 24h tape is led by Injective.
Quick winners
Full comparison
| Metric | INJ | CHEEMS |
|---|---|---|
| Price | $5.15 | $1,880.52 |
| Market Cap | $490.41M | $101.14M |
| FDV | — | — |
| Volume 24h | $2.50M | $279,632.00 |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 98.00 | 254.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.97% | +3.64% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | INJ | CHEEMS |
|---|---|---|
| 1H | — | — |
| 24H | +5.19% | +4.60% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | INJ | CHEEMS |
|---|---|---|
| RSI | 49.29 | 49.02 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.29 | 67.35 |
| ADX | 12.19 | 21.33 |
| Support | 4.91 | 1,827.82 |
| Resistance | 5.47 | 1,960.30 |
| Trend | neutral | bearish |
| Momentum | — | 63.00 |
| Signal | neutral | neutral |
Automatic technical analysis
Relative technical health favors reading both charts side by side. AI scores (48.70 vs 58.40) summarize PEPS modules, but supports and resistances still decide invalidation.
Fundamentals
| Metric | INJ | CHEEMS |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 0.00 | — |
| Github activity | 118.00 | — |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Injective
CHEEMS
Pros and cons
Pros of Injective
- Higher ranking for Injective can translate into tighter spreads on major venues.
- Market-cap scale on Injective may dampen some idiosyncratic shocks versus smaller peers.
- Composite PEPS readings for Injective can surface clearer module agreement during trend phases.
Cons of Injective
- Large-cap status for Injective can mean slower percentage upside versus high-beta alternatives.
- Indicator stacks on Injective may stay stretched longer than expected in strong trends.
Pros of CHEEMS
- Diversifying versus Injective with CHEEMS can change portfolio factor exposure.
- Narrative optionality around CHEEMS can reprice quickly when catalysts appear.
- If technical momentum aligns, CHEEMS may outperform on medium-term windows.
- Active volume bursts on CHEEMS sometimes precede sharper tactical moves.
Cons of CHEEMS
- Smaller book depth versus large caps can increase slippage for CHEEMS.
- Incomplete fundamental coverage can hide operational or tokenomic risks.
Which looks stronger right now?
If you weight capitalization and liquidity, Injective looks sturdier; if you weight 24h tape, Injective is ahead. A balanced view treats both as incomplete signals.
AI summary
In about three hundred words of context: Injective (INJ) trades near $5.15 with a +5.19% day move, while CHEEMS (CHEEMS) is around $1,880.52 (+4.60%). Volume leadership currently sits with Injective, and market-cap leadership with Injective. Technical trend labels read neutral vs bearish, with RSI near 49.29/49.02. Bottom line: use this page as a structured checklist, then open each coin page and related PEPS tools before acting. Nothing here is financial advice.
FAQ
Which is better, Injective or CHEEMS?
“Better” depends on horizon and risk. Injective leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, INJ or CHEEMS?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Injective and CHEEMS.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.